EU TRANSPARENCY REGISTER · 279842953110-22 · Serbia

HEMOFARM AКCIONARSKO DRUŠTVO FARMACEUTSKO-HEMIJSKA INDUSTRIJA VRŠAC

HEMOFARM AD

Category

Companies & groups

Country

Serbia

Vrsac

Entity form

joint venture company

Stated objectives

Hemofarm A.D., established in Vršac, Serbia, in 1960, has evolved into the region's premier generic pharmaceutical entity. As a subsidiary of the global STADA Group since 2006, it underscores a commitment to crafting accessible, high-qualit…

As declared by the registrant. Truncated to 240 characters; full text on the upstream profile.

Official profile

The full record on the Joint Transparency Register carries financial information (lobby budget, EU funding received), the list of named accredited representatives, declared interests of those persons, and a history of meetings with Commission officials.

Registered

2024-03-04

Last updated

2026-02-25

Other Companies & groups in Serbia

Other registered organisations in Serbia

Frequently asked questions

What is this organisation?
HEMOFARM AКCIONARSKO DRUŠTVO FARMACEUTSKO-HEMIJSKA INDUSTRIJA VRŠAC (HEMOFARM AD) is an interest representative listed in the EU Joint Transparency Register under ID 279842953110-22. Entity form: joint venture company.
What category is it registered under?
It is registered under the category "Companies & groups".
Which country is it based in?
The organisation is based in Serbia, Vrsac.
What are its stated goals?
As declared by the registrant: Hemofarm A.D., established in Vršac, Serbia, in 1960, has evolved into the region's premier generic pharmaceutical entity. As a subsidiary of the global STADA Group since 2006, it underscores a commitment to crafting accessible, high-qualit…
Where can I find its EU Transparency Register entry?
The full register entry — including lobby budget, EU funding received, accredited representatives and Commission meetings — is available on the EU Transparency Register under ID 279842953110-22.

Source: EU Joint Transparency Register (Council / Commission / Parliament) · refreshed 2026-07-01 · Commission Reuse Decision 2011/833/EU